Camurus Revenue and Competitors

Claim your profile

Lund, Sweden

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Camurus's estimated annual revenue is currently $37.2M per year.(i)
  • Camurus's estimated revenue per employee is $201,000

Employee Data

  • Camurus has 185 Employees.(i)
  • Camurus grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.9M749%N/AN/A
#2
$37.2M18511%N/AN/A
#3
$18.5M9219%N/AN/A
#4
$72.8M36225%N/AN/A
#5
$1200M106690%$2.4BN/A
#6
$5.6M2856%N/AN/A
#7
$6.6M33106%N/AN/A
#8
$21.7M108731%N/AN/A

Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.

keywords:N/A

N/A

Total Funding

185

Number of Employees

$37.2M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Camurus News

2022-04-17 - Nanotechnology in Drug Delivery Market Size, Share, Growth ...

Nanotechnology in Drug Delivery Market Size, Share, Growth 2022-2029| Key Players – Access Pharmaceuticals, Alkermes, Aquanova, Camurus.

2022-04-17 - Nanocapsules Market Inclinations and Development Status ...

... for the Forecast Period Between 2022 to 2028: BioDelivery Sciences, Camurus, Carlina Technologies, Cerulean Pharma, Nano Green Sciences.

2022-04-06 - Camurus : Proposal by the Board on authorization for the Board of Directors to resolve on issues

Camurus : Proposal by the Board on authorization for the Board of Directors to resolve on issues · 1. The authorization may be exercised on one...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.1M18821%N/A
#2
$35M19622%N/A
#3
$33M207N/AN/A
#4
$47.2M2963%N/A
#5
$15M33425%N/A